Alamar Biosciences, Inc. — Investor Relations & Filings
Alamar Biosciences, Inc. is a commercial-stage proteomics company focused on powering precision proteomics for the earliest detection of disease. It develops and commercializes an automated, high-throughput, ultra-high sensitivity platform, including ARGO™ and NULISA™ technologies. This platform redefines protein biomarker detection by enabling the discovery of novel plasma biomarkers, even from low-volume specimens, that are often invisible with conventional immunoassays. The technology supports groundbreaking insights in biomarker discovery, drug development, and disease research, expanding applications across various conditions like Alzheimer's, TBI, and stroke, from pediatric to geriatric care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-08 | English | |
| 8-K | 2026-05-08 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Regulatory Filings 2026 | 2026-04-21 | English | |
| S-8 | 2026-04-20 | English |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46725313 | 10-Q | 2026-05-08 | English | ||
| 46725306 | 8-K | 2026-05-08 | English | ||
| 46725314 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725315 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725316 | Regulatory Filings 2026 | 2026-04-21 | English | ||
| 46725319 | S-8 | 2026-04-20 | English | ||
| 46725321 | 8-K | 2026-04-20 | English | ||
| 46725323 | POS AM | 2026-04-20 | English | ||
| 46725325 | 424B4 | 2026-04-17 | English | ||
| 46725326 | Regulatory Filings 2026 | 2026-04-17 | English | ||
| 46725329 | S-1MEF | 2026-04-17 | English | ||
| 46725328 | Regulatory Filings 2026 | 2026-04-16 | English | ||
| 46725327 | S-1/A | 2026-04-16 | English | ||
| 46725330 | 8-A12B | 2026-04-15 | English | ||
| 46725336 | S-1/A | 2026-04-13 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMV Inc.
Pioneering novel immunotherapies using the proprietary DPX®…
|
IMV | CA | Professional, scientific and te… |
|
INBIOGEN CO.,Ltd
A life sciences firm offering bioinformatics and data minin…
|
101140 | KR | Professional, scientific and te… |
|
Incannex Healthcare Inc.
A clinical-stage biopharma firm developing cannabinoid and …
|
IXHL | US | Professional, scientific and te… |
|
Indaptus Therapeutics, Inc.
Develops bacterial-based immunotherapies for cancer and vir…
|
INDP | US | Professional, scientific and te… |
|
InflaRx N.V.
Clinical-stage biopharmaceutical firm developing C5a/C5aR p…
|
IFRX | NL | Professional, scientific and te… |
|
Inhalation Sciences Sweden AB
Develops lab instruments and provides research for preclini…
|
ISAB | SE | Professional, scientific and te… |
|
Initiator Pharma A/S
Clinical-stage company developing drugs for central and per…
|
INIT | DK | Professional, scientific and te… |
|
Inmolecule Nanotech, S.A.
Develops nanoparticles from plant compounds for biomedical …
|
MLINA | ES | Professional, scientific and te… |
|
InNexus Biotechnology Inc.
Develops enhanced monoclonal antibodies and diagnostics usi…
|
IXSBF | CA | Professional, scientific and te… |
|
Inotiv, Inc.
A CRO providing nonclinical drug development services and r…
|
NOTV | US | Professional, scientific and te… |
Alamar Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72612/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72612 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72612 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72612 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72612}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alamar Biosciences, Inc. (id: 72612)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.